Top Markets
Coin of the day
Pharmena S.a. Pharmena S.a.

Pharmena S.a.

PHR
Rang in Aktien #32515
Pharmena S.A. engages in the sale of dietary supplements in Poland and... Pharmena S.A. engages in the sale of dietary supplements in Poland and internationally. It also develops 1-MNA (PHR-701 program), a medical device for use in difficult-to-heal wounds. In addition, the company is involved in research and development of therapeutic applications of 1 MNA as an anti-inflammatory and anti-fibrotic drug; and research and development at pulmonary fibrosis, respiratory tract infections, including viral infections, COVID-19, inflammatory diseases, metabolic diseases and other therapeutic applications. Pharmena S.A. was founded in 2002 and is based in Lódz, Poland. Pharmena S.A. operates as a subsidiary of Pelion S.A.
Aktienkurs
$0.88679187
Marktkapitalisierung
$9.88M
Veränderung (1 Tag)
-1.56%
Veränderung (1 Jahr)
-7.31%
Land
PL
Handel Pharmena S.a. (PHR)

Kategorie

Kursverlauf für Pharmena S.a. (PHR)
Höchster Schlusskurs: $0.88 am 2026-08-01

Niedrigster Schlusskurs: $11.61 am 2008-08-01
Kursverlauf der Aktie von Pharmena S.a. von 2008 bis 2026
Jährliche Kursentwicklung
Jahr Leistung
2026 (TTM) 15.04%
2025 -21.82%
2024 -32.78%
2023 22.29%
2022 -38.58%
2021 -21.12%
2020 71.82%
2019 -23.56%
2018 -69.62%
2017 62.77%
2016 -28.11%
2015 108.99%
2014 -17.86%
2013 48.88%
2012 -70.22%
2011 -12.90%
2010 -5.94%
2009 13.15%
2008 0.00%
Aktienkurs vergleichbarer Unternehmen oder Wettbewerber
Unternehmen Aktienkurs Veränderung 1J% Land
$515.58 31.26%
US
$992.01 51.72%
NL
$736.64 7.19%
CH
$1.07K -6.40%
KR
$255.50 13.38%
BE